LifeStance Health (LFST) Operating Expenses (2020 - 2026)

LifeStance Health (LFST) has 7 years of Operating Expenses data on file, last reported at $381.2 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $381.2 million, up 15.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 billion (up 11.82% YoY), and the FY2025 annual result was $1.4 billion, up 9.17% from the prior year.
• Operating Expenses improved to $381.2 million in Q1 2026 per LFST's latest filing, from $364.1 million in the prior quarter.
• Over five years, Operating Expenses peaked at $381.2 million in Q1 2026 and troughed at $256.4 million in Q3 2022.
• A 5-year average of $316.4 million and a median of $317.2 million in 2024 frame the typical range for Operating Expenses.
• On a YoY basis, Operating Expenses climbed as much as 86.06% in 2022 and fell as far as 14.11% in 2022.
• A 5-year view of Operating Expenses shows it stood at $275.4 million in 2022, then increased by 13.62% to $312.9 million in 2023, then advanced by 3.69% to $324.4 million in 2024, then grew by 12.23% to $364.1 million in 2025, then climbed by 4.69% to $381.2 million in 2026.
• Business Quant data shows LFST's Operating Expenses at $381.2 million in Q1 2026, $364.1 million in Q4 2025, and $356.4 million in Q3 2025.